In summary, we identified a novel oncogenic circRNA-circMYOF in PDA. We also highlight that targeting the circMYOF/miR-4739/VEGFA/PI3K/AKT axis may be a promising strategy for the treatment of PDA. In the future, it is worthy investigating the potential regulatory mechanism on circMYOF expression.
CircMYOF triggers progression and facilitates glycolysis via the VEGFA/PI3K/AKT axis by absorbing miR-4739 in pancreatic ductal adenocarcinoma.